Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
10
Mins
23rd November 2023
A New Landmark for Wellbeing in Psoriasis: The POSITIVE Study
Psoriatic disease is a chronic, inflammatory immune condition affecting more than 40 million individuals worldwide…
1
Mins
23rd November 2023
The Safety Profile of Biological Agents in Patients with Psoriasis and HIV: A Systematic Review
Patients with HIV and severe psoriasis who require biological agents are thus thought to be at increased risk of adverse events….
5
Mins
23rd November 2023
Clinical Practice Guideline Updates
Barbara Trautner, Baylor College of Medicine, Houston, Texas, USA, presented the inaugural clinical practice guidelines for treating…
22nd November 2023
Live Webinar: ECLS with Xenios console | December 12th 7:30 AM - 8:30 AM CET
Join us to get to know Fresenius Medical Care’s ECMO offering – a dedicated technology combining both, heart and lung support in one single platform.
1
Mins
22nd November 2023
Neurofilament Light Chain Levels Predict Multiple Sclerosis Disability Progression
According to new research, elevation of serum neurofilament light chain, a biomarker of neuroaxonal injury, can predict disability worsening in multiple sclerosis within 1–2 years.
1
Mins
21st November 2023
Does Herpes Simplex Virus 1 Increase Risk of Alzheimer’s Disease?
New evidence suggests that herpes simplex virus 1 may be associated with an increased risk for Alzheimer’s disease, according to a systematic review of published studies.
Dr Peter Ahnesorg on why leaders must never stop learning
Peter Ahnesorg, Global Hematology Franchise Head, Roche, talks about his background in biochemistry, his hopes for the haematology space and his approach to leadership.
Hematology: where's it been and where's it going?
Discover the past and future of hematology. Uncover the challenges, advancements, and the industry’s commitment to patient well-being.
Meet GOLD’s latest catalyst – Roche’s Dr Peter Ahnesorg
Tune in for a sneak peek of GOLD’s latest Catalyst interview with Dr Peter Ahnesorg, Global Hematology Franchise Head, Roche.
7
Mins
20th November 2023
A Review of Oral Fixed-Dose Sodium Phenylbutyrate and Ursodoxicoltaurine in People with Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that is estimated to affect approximately 300,000 individuals worldwide…
←
1
2
3
…
139
140
141
142
143
144
145
…
866
867
868
→